Copeptin Levels Before and After Transsphenoidal Surgery for Cushing Disease: A Potential Early Marker of Remission.
Chelsi FlippoChristina TatsiNinet SinaiiMaria De La Luz SierraElena BelyavskayaCharalampos LyssikatosMeg KeilElias SpanakisConstantine A StratakisPublished in: Journal of the Endocrine Society (2022)
A difference in peak postoperative plasma copeptin as an early marker to predict remission of CD was not consistently present, although the data point to the need for a larger sample size to further evaluate this. However, the utility of this test may be limited to those who develop neither DI nor SIADH postoperatively.
Keyphrases
- disease activity
- minimally invasive
- ulcerative colitis
- coronary artery bypass
- patients undergoing
- electronic health record
- rheumatoid arthritis
- systemic lupus erythematosus
- surgical site infection
- human health
- machine learning
- staphylococcus aureus
- risk assessment
- acute coronary syndrome
- coronary artery disease
- climate change
- pseudomonas aeruginosa